_id
690db1a1ccc777a4e85d0c07
Ticker
ASH
Name
Ashland Global Holdings Inc
Exchange
NYSE
Address
8145 Blazer Drive, Wilmington, DE, United States, 19808
Country
USA
Sector
Basic Materials
Industry
Specialty Chemicals
Currency
USD
Website
https://www.ashland.com
Description
Ashland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; and nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; agricultural chemicals; diagnostic films; and fine chemicals. Its Personal Care segment provides a range of natural, nature-derived, biodegradable, and performance ingredients; solutions for toothpastes, mouth washes and rinses, denture cleaning, and care for teeth; and household supplies nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers. The Specialty Additives segment offers rheology modifiers, foam control agents, surfactants and wetting agents, pH neutralizers, advanced ceramics used in catalytic converters, environmental filters, ingredients for the manufacturing of ceramic capacitors, plasma display panels and solar cells, ingredients for textile printing, thermoplastic metals, and alloys for welding. Its Intermediates segment produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone. It offers its products to customers in a range of consumer and industrial markets, such as architectural coatings, construction, energy, food and beverage, personal care, and pharmaceutical. The company was formerly known as Ashland Global Holdings Inc. and changed its name to Ashland Inc. in August 2022. Ashland Inc. was founded in 1924 and is headquartered in Wilmington, Delaware.
Last Close
59.84
Volume
863714
Current Price
60.62
Change
1.303475935828867
Last Updated
2025-11-28T12:26:27.259Z
Image
-
Ipo Date
1983-04-06T00:00:00.000Z
Market Cap
2402029568
Next Dividend Date
2025-12-15T00:00:00.000Z
Dividend Frequency
Quarterly
Dividend Rate
0.415
Dividend Yield
2.774064171122994
Sentiment
0.9522461538461537
Sentiment Sources
13
Rating
4.1818
Target Price
63.2
Strong Buy
6
Buy
1
Hold
4
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
478000000
Cost Of Revenue
319000000
Gross Profit
159000000
Operating Expenses
98000000
Operating Income
61000000
Interest Expense
16000000
Pretax Income
64000000
Net Income
32000000
Eps
0.6956521739130435
Dividends Per Share
19000000
Shares Outstanding
45718113
Income Tax Expense
31000000
EBITDA
130000000
Operating Margin
12.761506276150628
Total Other Income Expense Net
3000000
Cash
207000000
Short Term Investments
-
Receivables
201000000
Inventories
567000000
Total Current Assets
1124000000
Property Plant Equipment
1302000000
Total Assets
4621000000
Payables
185000000
Short Term Debt
21000000
Long Term Debt
1384000000
Total Liabilities
2732000000
Equity
1889000000
Depreciation
76000000
Change In Working Capital
68000000
Cash From Operations
106000000
Capital Expenditures
20000000
Cash From Investing
1000000
Cash From Financing
-70000000
Net Change In Cash
39000000
PE
-
PB
1.4571942826892534
ROE
1.694017998941239
ROA
0.6924908028565245
FCF
86000000
Fcf Percent
0.1799163179916318
Piotroski FScore
4
Health Score
59
Deep Value Investing Score
7
Defensive Investing Score
7.5
Dividend Investing Score
4
Economic Moat Investing Score
5.3
Garp Investing Score
3
Growth Investing Score
2.5
Momentum Investing Score
3
Net Net Investing Score
2.5
Quality Investing Score
5
Value Investing Score
6.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
478000000
Quarters > 0 > income Statement > cost Of Revenue
319000000
Quarters > 0 > income Statement > gross Profit
159000000
Quarters > 0 > income Statement > operating Expenses
98000000
Quarters > 0 > income Statement > operating Income
61000000
Quarters > 0 > income Statement > interest Expense
16000000
Quarters > 0 > income Statement > pretax Income
64000000
Quarters > 0 > income Statement > net Income
32000000
Quarters > 0 > income Statement > eps
0.6956521739130435
Quarters > 0 > income Statement > dividends Per Share
19000000
Quarters > 0 > income Statement > shares Outstanding
46000000
Quarters > 0 > income Statement > income Tax Expense
31000000
Quarters > 0 > income Statement > EBITDA
130000000
Quarters > 0 > income Statement > operating Margin
12.761506276150628
Quarters > 0 > income Statement > total Other Income Expense Net
3000000
Quarters > 0 > balance Sheet > cash
207000000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
201000000
Quarters > 0 > balance Sheet > inventories
567000000
Quarters > 0 > balance Sheet > total Current Assets
1124000000
Quarters > 0 > balance Sheet > property Plant Equipment
1302000000
Quarters > 0 > balance Sheet > total Assets
4621000000
Quarters > 0 > balance Sheet > payables
185000000
Quarters > 0 > balance Sheet > short Term Debt
21000000
Quarters > 0 > balance Sheet > long Term Debt
1384000000
Quarters > 0 > balance Sheet > total Liabilities
2732000000
Quarters > 0 > balance Sheet > equity
1889000000
Quarters > 0 > cash Flow > net Income
-741000000
Quarters > 0 > cash Flow > depreciation
76000000
Quarters > 0 > cash Flow > change In Working Capital
68000000
Quarters > 0 > cash Flow > cash From Operations
106000000
Quarters > 0 > cash Flow > capital Expenditures
20000000
Quarters > 0 > cash Flow > cash From Investing
1000000
Quarters > 0 > cash Flow > cash From Financing
-70000000
Quarters > 0 > cash Flow > net Change In Cash
39000000
Quarters > 0 > ratios > PE
0.6956521739130435
Quarters > 0 > ratios > PB
1.4571942826892534
Quarters > 0 > ratios > ROE
1.694017998941239
Quarters > 0 > ratios > ROA
0.6924908028565245
Quarters > 0 > ratios > FCF
86000000
Quarters > 0 > ratios > Piotroski FScore
4
Quarters > 0 > ratios > fcf Percent
0.1799163179916318
Quarters > 0 > health Score
59
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
463000000
Quarters > 1 > income Statement > cost Of Revenue
331000000
Quarters > 1 > income Statement > gross Profit
132000000
Quarters > 1 > income Statement > operating Expenses
840000000
Quarters > 1 > income Statement > operating Income
-708000000
Quarters > 1 > income Statement > interest Expense
15000000
Quarters > 1 > income Statement > pretax Income
-704000000
Quarters > 1 > income Statement > net Income
-742000000
Quarters > 1 > income Statement > eps
-16.130434782608695
Quarters > 1 > income Statement > dividends Per Share
19000000
Quarters > 1 > income Statement > shares Outstanding
46000000
Quarters > 1 > income Statement > income Tax Expense
15000000
Quarters > 1 > income Statement > EBITDA
-613000000
Quarters > 1 > income Statement > operating Margin
-152.9157667386609
Quarters > 1 > income Statement > total Other Income Expense Net
4000000
Quarters > 1 > balance Sheet > cash
207000000
Quarters > 1 > balance Sheet > short Term Investments
67000000
Quarters > 1 > balance Sheet > receivables
201000000
Quarters > 1 > balance Sheet > inventories
567000000
Quarters > 1 > balance Sheet > total Current Assets
1124000000
Quarters > 1 > balance Sheet > property Plant Equipment
1302000000
Quarters > 1 > balance Sheet > total Assets
4621000000
Quarters > 1 > balance Sheet > payables
185000000
Quarters > 1 > balance Sheet > short Term Debt
19000000
Quarters > 1 > balance Sheet > long Term Debt
1382000000
Quarters > 1 > balance Sheet > total Liabilities
2732000000
Quarters > 1 > balance Sheet > equity
1889000000
Quarters > 1 > cash Flow > net Income
-719000000
Quarters > 1 > cash Flow > depreciation
122000000
Quarters > 1 > cash Flow > change In Working Capital
68000000
Quarters > 1 > cash Flow > cash From Operations
133000000
Quarters > 1 > cash Flow > capital Expenditures
20000000
Quarters > 1 > cash Flow > cash From Investing
-63000000
Quarters > 1 > cash Flow > cash From Financing
-70000000
Quarters > 1 > cash Flow > net Change In Cash
39000000
Quarters > 1 > ratios > PE
-16.130434782608695
Quarters > 1 > ratios > PB
1.4571942826892534
Quarters > 1 > ratios > ROE
-39.280042350449975
Quarters > 1 > ratios > ROA
-16.057130491235664
Quarters > 1 > ratios > FCF
113000000
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
0.24406047516198703
Quarters > 1 > health Score
44
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
479000000
Quarters > 2 > income Statement > cost Of Revenue
332000000
Quarters > 2 > income Statement > gross Profit
147000000
Quarters > 2 > income Statement > operating Expenses
96000000
Quarters > 2 > income Statement > operating Income
51000000
Quarters > 2 > income Statement > interest Expense
15000000
Quarters > 2 > income Statement > pretax Income
39000000
Quarters > 2 > income Statement > net Income
31000000
Quarters > 2 > income Statement > eps
0.6595744680851063
Quarters > 2 > income Statement > dividends Per Share
19000000
Quarters > 2 > income Statement > shares Outstanding
47000000
Quarters > 2 > income Statement > income Tax Expense
9000000
Quarters > 2 > income Statement > EBITDA
114000000
Quarters > 2 > income Statement > operating Margin
10.647181628392484
Quarters > 2 > income Statement > total Other Income Expense Net
-12000000
Quarters > 2 > balance Sheet > cash
168000000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
226000000
Quarters > 2 > balance Sheet > inventories
542000000
Quarters > 2 > balance Sheet > total Current Assets
1075000000
Quarters > 2 > balance Sheet > property Plant Equipment
1318000000
Quarters > 2 > balance Sheet > total Assets
5233000000
Quarters > 2 > balance Sheet > payables
185000000
Quarters > 2 > balance Sheet > short Term Debt
69000000
Quarters > 2 > balance Sheet > long Term Debt
1336000000
Quarters > 2 > balance Sheet > total Liabilities
2674000000
Quarters > 2 > balance Sheet > equity
2559000000
Quarters > 2 > cash Flow > net Income
31000000
Quarters > 2 > cash Flow > depreciation
60000000
Quarters > 2 > cash Flow > change In Working Capital
-65000000
Quarters > 2 > cash Flow > cash From Operations
1000000
Quarters > 2 > cash Flow > capital Expenditures
21000000
Quarters > 2 > cash Flow > cash From Investing
17000000
Quarters > 2 > cash Flow > cash From Financing
-69000000
Quarters > 2 > cash Flow > net Change In Cash
-51000000
Quarters > 2 > ratios > PE
0.6595744680851063
Quarters > 2 > ratios > PB
1.099054318093005
Quarters > 2 > ratios > ROE
1.211410707307542
Quarters > 2 > ratios > ROA
0.5923944200267534
Quarters > 2 > ratios > FCF
-20000000
Quarters > 2 > ratios > Piotroski FScore
3
Quarters > 2 > ratios > fcf Percent
-0.04175365344467641
Quarters > 2 > health Score
42
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
405000000
Quarters > 3 > income Statement > cost Of Revenue
294000000
Quarters > 3 > income Statement > gross Profit
111000000
Quarters > 3 > income Statement > operating Expenses
290000000
Quarters > 3 > income Statement > operating Income
-179000000
Quarters > 3 > income Statement > interest Expense
15000000
Quarters > 3 > income Statement > pretax Income
-209000000
Quarters > 3 > income Statement > net Income
-165000000
Quarters > 3 > income Statement > eps
-3.4970222325837694
Quarters > 3 > income Statement > dividends Per Share
19000000
Quarters > 3 > income Statement > shares Outstanding
47183000
Quarters > 3 > income Statement > income Tax Expense
-43000000
Quarters > 3 > income Statement > EBITDA
-143000000
Quarters > 3 > income Statement > operating Margin
-44.19753086419753
Quarters > 3 > income Statement > total Other Income Expense Net
-30000000
Quarters > 3 > balance Sheet > cash
219000000
Quarters > 3 > balance Sheet > short Term Investments
73000000
Quarters > 3 > balance Sheet > receivables
163000000
Quarters > 3 > balance Sheet > inventories
528000000
Quarters > 3 > balance Sheet > total Current Assets
1069000000
Quarters > 3 > balance Sheet > property Plant Equipment
1333000000
Quarters > 3 > balance Sheet > total Assets
5231000000
Quarters > 3 > balance Sheet > payables
184000000
Quarters > 3 > balance Sheet > short Term Debt
20000000
Quarters > 3 > balance Sheet > long Term Debt
1313000000
Quarters > 3 > balance Sheet > total Liabilities
2639000000
Quarters > 3 > balance Sheet > equity
2592000000
Quarters > 3 > cash Flow > net Income
-165000000
Quarters > 3 > cash Flow > depreciation
51000000
Quarters > 3 > cash Flow > change In Working Capital
-109000000
Quarters > 3 > cash Flow > cash From Operations
-40000000
Quarters > 3 > cash Flow > capital Expenditures
23000000
Quarters > 3 > cash Flow > cash From Investing
-18000000
Quarters > 3 > cash Flow > cash From Financing
-22000000
Quarters > 3 > cash Flow > net Change In Cash
-81000000
Quarters > 3 > ratios > PE
-3.4970222325837694
Quarters > 3 > ratios > PB
1.0892865432098766
Quarters > 3 > ratios > ROE
-6.365740740740741
Quarters > 3 > ratios > ROA
-3.1542726056203403
Quarters > 3 > ratios > FCF
-63000000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-0.15555555555555556
Quarters > 3 > health Score
25
Valuation > metrics > PE
0.6956521739130435
Valuation > metrics > PB
1.4571942826892534
Valuation > final Score
100
Valuation > verdict
46.5% Undervalued
Profitability > metrics > ROE
1.694017998941239
Profitability > metrics > ROA
2.8469750889679712
Profitability > metrics > Net Margin
0.06694560669456066
Profitability > final Score
22
Profitability > verdict
Weak
Risk > metrics > Debt Equity
1.4462678665960826
Risk > metrics > Interest Coverage
3.8125
Risk > final Score
45
Risk > verdict
High
Liquidity > metrics > Current Ratio
5.456310679611651
Liquidity > metrics > Quick Ratio
2.703883495145631
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
100
Prev Valuations > 2
80
Prev Profitabilities > 0
0
Prev Profitabilities > 1
21
Prev Profitabilities > 2
0
Prev Risks > 0
-159
Prev Risks > 1
44
Prev Risks > 2
-18
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-12T14:00:49.133Z
Ashland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; and nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; agricultural chemicals; diagnostic films; and fine chemicals. Its Personal Care segment provides a range of natural, nature-derived, biodegradable, and performance ingredients; solutions for toothpastes, mouth washes and rinses, denture cleaning, and care for teeth; and household supplies nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers. The Specialty Additives segment offers rheology modifiers, foam control agents, surfactants and wetting agents, pH neutralizers, advanced ceramics used in catalytic converters, environmental filters, ingredients for the manufacturing of ceramic capacitors, plasma display panels and solar cells, ingredients for textile printing, thermoplastic metals, and alloys for welding. Its Intermediates segment produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone. It offers its products to customers in a range of consumer and industrial markets, such as architectural coatings, construction, energy, food and beverage, personal care, and pharmaceutical. The company was formerly known as Ashland Global Holdings Inc. and changed its name to Ashland Inc. in August 2022. Ashland Inc. was founded in 1924 and is headquartered in Wilmington, Delaware.
Stock Price
$ 0.00
0% increase compared to yesterday.
Dividend
Frequency:
Rate:
0.415Next Payout:
Dec 15, 2025Yield:
2.7741 %Evaxion Biotech stock holds Buy rating at H.C. Wainwright after ASH data - Investing.com Canada
12/10/2025
Evaxion Biotech stock holds Buy rating at H.C. Wainwright after ASH data Investing.com Canada
Read more →Evaxion Biotech stock holds Buy rating at H.C. Wainwright after ASH data - Investing.com UK
12/10/2025
Evaxion Biotech stock holds Buy rating at H.C. Wainwright after ASH data Investing.com UK
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$63.2
Analyst Picks
Strong Buy
6
Buy
1
Hold
4
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 70.86% of the total shares of Ashland Global Holdings Inc
1.
Vanguard Group Inc(10.1763%)
since
2025/06/30
2.
BlackRock Inc(9.8575%)
since
2025/03/31
3.
AQR Capital Management LLC(7.5584%)
since
2025/06/30
4.
Massachusetts Financial Services Company(6.2297%)
since
2025/06/30
5.
Dimensional Fund Advisors, Inc.(5.4986%)
since
2025/06/30
6.
Allspring Global Investments Holdings, LLC(5.0128%)
since
2025/03/31
7.
Cooperman Leon G(3.7194%)
since
2025/06/30
8.
State Street Corp(3.3872%)
since
2025/03/31
9.
Diamond Hill Capital Management Inc(3.2753%)
since
2025/06/30
10.
1832 Asset Management L.P(3.0013%)
since
2025/06/30
11.
Shapiro Capital Management Co Inc(1.8654%)
since
2025/06/30
12.
Geode Capital Management, LLC(1.7951%)
since
2025/03/31
13.
Charles Schwab Investment Management Inc(1.3217%)
since
2025/06/30
14.
Qube Research & Technologies(1.2584%)
since
2025/06/30
15.
D. E. Shaw & Co LP(1.2518%)
since
2025/06/30
16.
Macquarie Group Ltd(1.1812%)
since
2025/03/31
17.
Newport Trust Co.(1.1708%)
since
2025/06/30
18.
Northern Trust Corp(1.1423%)
since
2025/03/31
19.
Morgan Stanley - Brokerage Accounts(1.0908%)
since
2025/03/31
20.
Bank of America Corp(1.0697%)
since
2025/03/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.